Caming, Xyle Drix .

HRN: 28-99-14  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2026
CEFTRIAXONE 1G (VIAL)
05/11/2026
05/17/2026
IVT
500mg
Q12H
T/C CNSI
Checking Initial Appropriateness 
05/13/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
05/13/2026
05/20/2026
IV
95mg
Q8H
CNSI
Checking Initial Appropriateness 
05/18/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
05/18/2026
05/25/2026
PO
4ml
Q8
T/c Begining CNS Abscess
Checking Initial Appropriateness 
05/18/2026
MUPIROCIN 2%, 15G (TUBE)
05/18/2026
12/14/1901
TOPICAL
15g
BID
T/c Cnsi
Checking Initial Appropriateness 
05/19/2026
MUPIROCIN 2%, 15G (TUBE)
05/19/2026
05/26/2026
TOPICAL
As Needed
BID
CNSI
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: